Municipal Employees' Retirement System Of Michigan Nektar Therapeutics Transaction History

Municipal Employees' Retirement System Of Michigan

$7.21 Billion
Q2 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 06, 2020	SELL	$16.86 - $23.44 $556,548 - $773,754	-33,010 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$14.47 - $27.96 $7,235 - $13,980	500 Added 1.54%	33,010 $589,000
Q4 2019 Feb 03, 2020	BUY	$15.87 - $23.12 $435,314 - $634,181	27,430 Added 539.96%	32,510 $702,000
Q2 2019 Jul 31, 2019	BUY	$31.0 - $36.3 $55,800 - $65,339	1,800 Added 54.88%	5,080 $181,000
Q1 2019 May 15, 2019	SELL	$31.58 - $46.35 $72,634 - $106,605	-2,300 Reduced 41.22%	3,280 $110,000
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $41,384 - $77,044	1,360 Added 32.23%	5,580 $183,000
Q1 2018 May 10, 2018	SELL	$57.4 - $108.44 $3.15 Million - $5.96 Million	-54,950 Reduced 92.87%	4,220 $448,000
Q4 2017 Feb 15, 2018	BUY	$23.02 - $60.5 $7,596 - $19,965	330 Added 0.56%	59,170 $3.53 Million
Q3 2017 Nov 06, 2017	BUY	$17.79 - $24.0 $1.05 Million - $1.41 Million	58,840	58,840 $1.41 Million

Others Institutions Holding NKTR

# of Institutions

140

Shares Held

135M

Call Options Held

32.8K

Put Options Held

55.5K

Deep Track Capital, LP Greenwich, CT

17.9M
Shares

$23.2 Million
0.73% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$19.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13M
Shares

$16.9 Million
0.0% of portfolio
Samlyn Capital, LLC New York, NY

9.46M
Shares

$12.3 Million
0.21% of portfolio
Eventide Asset Management, LLC Boston, MA

7.53M
Shares

$9.79 Million
0.16% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Municipal Employees' Retirement System Of Michigan, based on Form 13F filings with the SEC.

News

Stay updated on Municipal Employees' Retirement System Of Michigan with notifications on news.

Account